Results 151 to 160 of about 88,489 (340)

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Dose-Dependent Effect of Atrial Natriuretic Peptide on Blood Pressure, Heart Rate, and Skin Blood Flow of Normal Volunteers

open access: bronze, 1986
J. P. Bussien   +8 more
openalex   +1 more source

Single-cell analysis identifies the CNP/GC-B/cGMP axis as marker and regulator of modulated VSMCs in atherosclerosis

open access: yesNature Communications
A balanced activity of cGMP signaling contributes to the maintenance of cardiovascular homeostasis. Vascular smooth muscle cells (VSMCs) can generate cGMP via three ligand-activated guanylyl cyclases, the NO-sensitive guanylyl cyclase, the atrial ...
Moritz Lehners   +9 more
doaj   +1 more source

Effects of Aldosterone and Atrial Natriuretic Peptide on Water and Electrolyte Homeostasis of Sick Neonates [PDF]

open access: bronze, 1989
Takatsugu Kojima   +4 more
openalex   +1 more source

Prognostic utility of advanced lung cancer inflammation index in heart failure with preserved ejection fraction

open access: yesESC Heart Failure, EarlyView.
The advanced lung cancer inflammation index (ALI) is an integrated marker of inflammation and nutritional status, calculated by body mass index × serum albumin / neutrophil‐to‐lymphocyte ratio. Low ALI levels were significantly associated with poor prognosis in elderly multimorbid HFpEF patients.
Daisuke Sakamoto   +19 more
wiley   +1 more source

Natriuretic Peptide assays revisited do we need pro-B-type natriuretic Peptide? [PDF]

open access: yes, 2011
Discovery of the endocrine function of the heart, which exerts a fundamental role in regulating cardiovascular homeostasis through atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP), has opened up a new field of research that has ...
A. Clerico, C. Passino, M. Emdin
core  

Implementation of guidelines for intravenous iron therapy in heart failure patients

open access: yesESC Heart Failure, EarlyView.
Abstract Aims We aim to evaluate the implementation of the 2021 ESC Guidelines regarding screening and treatment of iron deficiency in patients with heart failure (HF) at Karolinska University Hospital. Methods and results Patients with left ventricular ejection fraction (LVEF) < 50% and New York Heart Association (NYHA) class II–IV who visited ...
Milou Gamage   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy